Focusing on the leading industries such as pharmaceutical health, the construction of the "two districts" in Changping achieved the "four new breakthroughs"!

Author:Beijing Changping officially r Time:2022.09.14

At the "two districts" construction conference (special session of the entire industrial chain of biomedicine) held on September 14, Changping District introduced in detail the results of the second anniversary of the "two districts" construction and the development of the characteristic industries of the Changping Group of the Young Trade. Happening.

Since 2020, in accordance with the unified deployment of the city, Changping District has closely linked the "five sons" linkage, seized the "two districts" opportunities, focused on the leading industries such as pharmaceutical health, continued to deepen reform and opening up, and achieved "four new breakthroughs".

Continuously strengthen policy empowerment

New breakthroughs in open development level

The first batch of 63 system innovation tasks in Changping's "two districts" were completed, and a number of "first creation cases" were formed around the fields of biomedical advantages and characteristics, including the nation's first decentralized clinical trial (DCT) pilot. Research hospitals, the city's first free trade group pharmaceutical and health industry promotion policy, the city has launched the "Ten Beauty Economy" and so on. This year, around the integration and innovation of the full chain, Changping District launched a new round of 128 tasks for the construction of the "two districts". The current completion rate is nearly 80%. The "two districts" construction driver continued to be prominent.

Empowerment through strengthening projects

New breakthroughs in the quality of industrial development

Changping District strengthened the "one library and four mechanisms", the promotion of the agglomeration project, and the development of the service industry. A number of major demonstration projects such as Nuocheng Jianhua Anti -Tumor Innovation Drug Production Base and Kexing Vaccine Quality Research Center has been accelerated; A number of professional service platforms such as the Gene therapy Innovation Center have been completed and put into operation one after another; a number of leading enterprises such as Baiji Shenzhou and Wantai Biological have expanded production and capacity; the Novartis R & D Center is in Changping, and the innovative medicine can be good for the project to complete the production license handling; Four companies in the district have been identified by the first batch of foreign -funded research and development centers in Beijing; more than 60 well -known scientists including Vitamaron and Youmai Galaxy have founded the enterprise to settle in the Life Science Park.

As a company that has a lot of benefits in the development of Changping's "two districts", after the Beijing Dart International Innovation Platform (hereinafter referred to as a dart accelerator) settled in the Life Science Park, Changping District collaborated with Zhongguancun Development Group to closely cooperate with the dart accelerator operation team to give full play to the full play. The darts accelerator's profound insight and innovative practice of the industrial ecology, as well as the gathering and connection function of market -oriented and international innovation service platforms, jointly promoted the upgrading of the medical and health industry of Changping District from a strategic level, and set up international first -class research acceleration in the Life Science Park Platform, cultivate the most cutting -edge pharmaceutical health innovation projects, create a model of biomedical innovation leading the world, and build a world -leading innovation ecosystem.

"Changping District has an international perspective and forward -looking. It has always been at the forefront of the development of the biomedical industry development. By implementing life technology to catch up with the project, strengthen original and leading basic research, accelerate the realization of technological innovation and product research and development Major breakthroughs support the improvement of biological economic innovation capabilities. "Zhu Pengcheng, the founder, chairman and CEO of Beijing Dartgow International Innovation Platform, introduced it. Jiang Maohua, deputy general manager, said that the construction of Changping's "two districts" was very significant. The industrial innovation, competitiveness, and radiation power in the field of biomedicine have been comprehensively improved, and the dart accelerator is also honored to land in Changping's "Valley of Life".

In the past two years, the "two districts" construction project has reached 520 projects, with an estimated investment of more than 110 billion yuan; the average annual growth rate of market entities in the region reached 12%, with a total of more than 180,000, of which the market entity of the Young Changping Group has exceeded 1 Wanjia has completed the three -year development goal in advance; eight companies including Ying Taijia and other companies have been successfully listed, and the development pattern of supporting and innovative enterprises has continued to improve. From January to July 2022, the total industrial output value of the company's groups above designated size achieved a total industrial output value of 18.48 billion yuan, an increase of 44%year-on-year, accounting for 25.4%of the total industrial output value of the region. This year, Changping District also formulated and implemented a multiplication action plan for the pharmaceutical and health industry, which will focus on the three tracks of cutting -edge technology, medical devices, and beautiful and healthy.

Strengthen service empowerment

New breakthroughs in market subject feelings

Changping District has launched the "Chang Cain" and "Changtong Office" brand, creating a service system with Changping characteristics to continue to improve corporate satisfaction. Changping District provides enterprises with high -quality services to enterprises in terms of major project service dispatching, scientific and technological services, financial services, and talent services. 22 high -tech enterprises in the district have realized the "application, identification, and reporting" of the enterprise, accounting for the first proportion in the city. Through the formulation of science and technology and financial policies, the capital technology achievement transformation fund was introduced, the parent fund group of the Changping science and technology industry industry was expanded, the multi -level parent fund system was established, the role of financial water was used, and the full -cycle of scientific and technological enterprises grew.

With the strong support of various departments of Changping District, since the end of 2021, Beijing Hutang Shenghua Medical Technology Co., Ltd. has developed a long -term development. It can provide more than 10 cells and gene therapy companies with innovative drug research and development and clinical clinical clinical each year. Test services, the income is expected to be less than 150 million yuan after the smooth operation. "Thanks to the construction of the two districts of Changping ', through the comprehensive implementation of the Changping tasks in the process of opening up the entire biomedicine industry chain, and the funds, policies, and coordination of various resources provided by the Changping District Government and various committees to form industries The positive cycle of the chain, the Tsinghua Institute of Industry Research Institute revolves around the CDMO platforms in the frontier fields such as genetic and cell therapy, antibody drugs, and put into use. "Hao Guoshun, deputy general manager of the strategic information of Hutang, said that the company's CDMO production platform will be As the core engine to promote the development of the biopharmaceutical industry, conform to the good trend of the construction of Changping's "two districts", provide commercialized custom R & D and production services for the products of pharmaceutical production enterprises and biotechnology companies, and provide pipeline enterprises in Changping District and even the country. better service. Strengthen ecological empowerment

New breakthroughs in scientific and technological innovation capabilities

Changping District has established the management model of "Management Committee+Platform Company+Professional Operation Team", based on the functional positioning of the science and technology innovation area, created the "1+1+N" innovation policy system, introduced to promote investment promotion, enterprise listing, high -tech enterprises Cultivate policies such as cultivation, continue to optimize the innovation ecology, and promote the integration and development of innovation chain, industrial chain, and supply chain. Over the past two years, various types of entities in the region have been fully stimulated, and nearly 20,000 patents have been added, with an average annual growth rate of 20%. The results of scientific and technological innovation have shown a "blowout" situation. Professor Li Wenhui of Beisheng Institute won the 2022 Future Science Award, a number of major original discovery of world influence, such as cell coke and anti -tumor immune function, hepatitis B virus pathogenic mechanism, etc. Waiting for a group of original innovative medicines to the world from Changping, a number of global and nationwide products such as "Cardiovascular AI Diagnosis Software", metal 3D printing orthopedic implant products, and artificial biological heart valve and other nationwide products were successively launched. Since the opening of the "Green Channel" of the National Innovation Medical Device in 2014, 21 innovative equipment approved by Changping District has reached 21, accounting for 12.1%of the country.

In the next step, Changping District will adhere to high levels of openness as a powerful driving force for promoting high -quality development, accelerate the opening of the entire industry chain of the biomedical industry, and build the Life Science Park into the world's leading science and technology park. "Two districts" construction display.

Graphic/stone crystal


- END -

On -site 丨 Vanke Yu Liang: This is the most stressful time since I was working

21st Century Business Herald reporter Wu Shuying Shenzhen ReportOn June 28, 2022, Vanke held an annual shareholders meeting in Shenzhen.At the shareholders' meeting, the chairman of Vanke's board of d...

Shenchuang Investment is on the list of shareholders, Yuchen Intelligent Seeking the IPO of the Science and Technology Board

Recently, Capital State learned that Shenzhen Yuchen Intelligent Equipment Co., Lt...